Public Health Webinar Series on Blood Disorders - 2014

Public Health Webinar Series on Blood Disorders

Archives for 2014

November 6, 2014

Gary E. Raskob, PhD, MSc
“Venous Thromboembolism: Recent Advances in Reducing the Disease Burden”External

Gary E. Raskob, PhD, MSc

In this webinar, Dr. Raskob reviewed the disease burden from venous thromboembolism. He also discussed strategies to reduce this burden through the prevention of first time and recurrent blood clots.

July 10, 2014

Lauren Marcewicz, MD
“Vitamin K and Vitamin K Deficiency Bleeding in Infants”External

Lauren Marcewicz, MD

In this presentation, Dr. Marcewicz reviewed how vitamin K works in infants, discussed the different classifications of vitamin K deficiency bleeding, and explained how to talk with parents about the administration of this important public health measure.

July 24, 2014

Connie Miller, PhD
“Inhibitor Testing: State of the Art”External

Connie Miller, PhD

In this presentation, Dr. Miller described the development of inhibitors in people who have hemophilia. She described different methods available for inhibitor testing and discussed the CDC laboratory’s role in national inhibitor monitoring.

To access the recording from this presentation, please click here.

April 3, 2014

Guy Young, MD
“New Challenges in Hemophilia”External

Guy Young, MD
Director, Hemostasis and Thrombosis Center at Children’s Hospital Los Angeles
Associate Professor of Pediatrics at the University of Southern California Keck School of Medicine

In this presentation, Dr. Young described many new changes that are coming to the field of hemophilia during the next few years, including new treatment strategies, new issues concerning bone health, and impacts of overweight and obesity. Dr. Young also addressed specific challenges for people with hemophilia who have an inhibitor.

February 6, 2014

Alok Khorana, MD
“Venous Thromboembolism and Cancer”External

Alok Khorana, MD
Director of the Gastrointestinal Malignancies Program at Taussig Cancer Institute of the Cleveland Clinic.

In this presentation, Dr. Khorana detailed the prevalence, consequences, and costs of venous thromboembolism (VTE) and described the importance of both predicting and preventing VTE in people who have cancer.

To access the slides from this presentation, please click here.


For more information on the webinar series, please contact Cindy Sayers at